We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LZM:NYSELifezone Metals Limited Analysis

Data as of 2026-04-16 - not real-time

$3.89

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Lifezone Metals is trading at $3.89, well below its 20‑day SMA of 3.58, 50‑day SMA of 4.14 and 200‑day SMA of 4.54, indicating a short‑term price weakness that still sits above the computed support level of 3.07 but below the resistance of 4.18. The RSI sits near the neutral 51 mark while the MACD histogram is positive, suggesting a tentative bullish momentum despite the overall bearish trend flag and a decreasing volume profile. Market sentiment is in the “Extreme Greed” zone (Fear‑Greed Index 88.98), and the upside/downside potential of 129% reflects a sizable price upside if the stock can break through resistance and sustain the bullish MACD signal.
Fundamentally, the company posts negative earnings, a trailing PE of zero, a forward PE of -9.97 and an astronomically high price‑to‑sales ratio of 330.8, underscoring weak profitability and heavy reliance on future growth. With a beta of 1.77, 30‑day volatility over 69%, a debt‑to‑equity of 73 and negative free cash flow, the balance sheet is strained, yet analysts have issued a “strong buy” rating and a mean price target of $8.93, implying the market may be undervaluing the Kabanga Nickel Project’s long‑term upside.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering above support but below key SMAs
  • Decreasing volume and high short‑term volatility
  • Positive MACD histogram hinting at a possible bounce

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst mean price target of $8.93 indicating ~130% upside
  • Potential upside from the Kabanga Nickel Project
  • Current market sentiment in extreme greed supporting rally

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Heavy debt load and persistent negative cash flows
  • Uncertainty around project financing and execution
  • Long‑term metal demand trends that could eventually improve fundamentals

Key Metrics & Analysis

Financial Health

Revenue Growth705.10%
P/E Ratio-10.0
ROE-16.39%
ROA-6.84%
Debt/Equity73.12
P/B Ratio4.4
Op. Cash Flow$-15592766
Free Cash Flow$-46555476

Technical Analysis

TrendBearish
RSI51.1
Support$3.07
Resistance$4.18
MA 20$3.58
MA 50$4.14
MA 200$4.54
MACDBullish
VolumeDecreasing
Fear & Greed Index88.98

Valuation

Target Price$8.93
Upside/Downside129.48%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.77
Volatility69.63%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.